Clinical Trials
5 trialsNCT06764095 2026-02-12
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Mayo Clinic
Phase 4 Recruiting
NCT05775471 2026-02-05
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT06262516 2025-09-05
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT02607709 2024-01-30
Lymphadenectomy in Urothelial Carcinoma
Zealand University Hospital
Phase NA Suspended
NCT00751140 2017-05-30
Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed